CRNX (NASDAQ: CRNX) insider sells shares via 10b5-1 and option exercise

Rhea-AI Filing Summary

CRNX: Notice of proposed and recent insider sales of Common Stock

The filing lists proposed transactions and recent dispositions by an insider. It shows a proposed exercise of stock options to sell 15,000 shares03/18/2026 and proposed settlement of 9,756 Restricted Stock Units03/15/2026. The filing also discloses three 10b5-1 sales of 5,000 shares each01/02/2026, 02/02/2026, and 03/02/2026 with proceeds of $232,590.50, $247,485.50, and $202,234.00, respectively.

Insights

Equity Compensation Analyst

Insider executed option exercise and reported planned share transfers plus routine 10b5-1 sales.

The filing documents a planned 15,000-share03/18/2026 and settlement of 9,756 RSUs03/15/2026. It also lists three completed 10b5-1 dispositions of 5,000 shares each on 01/02/2026, 02/02/2026, and 03/02/2026 with reported proceeds.

These entries are consistent with compensation-related liquidity events and pre-arranged trading; cash-flow treatment is tied to the insider's exercises and plan sales. Subsequent filings may disclose net shares retained post-transactions.

Securities Compliance Officer

Transactions show use of a 10b5-1 plan and standard issuer settlement mechanics.

The disclosure names 10b5-1 sales01/02/2026, 02/02/2026, and 03/02/2026. The planned option exercise and RSU settlement are listed as issuer-related events on their stated dates.

Regulatory filings accompanying these actions should show final settlement and any tax-withholding; review subsequent reports for confirmation of executed sale volumes and net proceeds.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	24756	938004.84	104705330	03/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2026	Exercise of Stock Options	Issuer			15000	03/18/2026	Cash
Common	03/15/2026	Restricted Stock Units	Issuer			9756	03/15/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for DANA PIZZUTI 6055 Lusk Boulevard San Diego CA 92121	Common	03/02/2026	5000	202234.00
10b5-1 Sales for DANA PIZZUTI 6055 Lusk Boulevard San Diego CA 92121	Common	02/02/2026	5000	247485.50
10b5-1 Sales for DANA PIZZUTI 6055 Lusk Boulevard San Diego CA 92121	Common	01/02/2026	5000	232590.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares did CRNX report proposing to sell?

The filing shows a proposed exercise-and-sale of 15,000 common shares03/18/2026 and settlement of 9,756 RSUs03/15/2026. These entries are listed under the securities to be sold.

What 10b5-1 sales by CRNX insider are disclosed?

Three 10b5-1 sales are reported: 5,000 shares01/02/2026, 02/02/2026, and 03/02/2026. Reported proceeds were $232,590.50, $247,485.50, and $202,234.00, respectively.

Who is identified as the selling party in the disclosed sales?

The 10b5-1 sales are attributed to an individual listed as Dana Pizzuti

Do the filings state how proceeds will be used by CRNX?

The filing does not attribute proceeds to the issuer; the entries reflect insider liquidity events and issuer settlement of RSUs and options. Specific use-of-proceeds language for the company is not included in the excerpt.